1.. Introduction
================

Emotions play a critical role in social relationship. There are three processes involving in inducing emotion: firstly, the emotional significance of a stimulus is recognized, then an affective state in response to that stimulus is produced, and finally integration of a cognitive process and an appropriate emotional regulation happens ([@B15]). In other words, emotion perception occurs after initial presentation of an emotive stimulus, which then allows the generation of complex affective state, emotional experience, and behavior ([@B4]).

Attention to emotion is an important component of emotion perception ([@B18]). The role of attention as a basic component in emotion perception has been evaluated in the study of Pessoa et al. ([@B14]). They tried to answer this question that whether the emotional stimulants need to be attended or the emotional process happens automatically. They showed different emotional images to the participants using the eye-tracking system and functional Magnetic Resonance Imaging. The results showed the inevitable presence of attention components in different reactions towards the arousal of emotional images ([@B14]).

Individual differences in emotional system play an important role in attention processing ([@B17]). For example, in a research conducted on young depressed patients using the eye-tracking system, it was reported that the patients spent much more time on fixation towards unpleasant scenes than pleasant or neutral ones ([@B11]).

Based on the conducted research in substance users, emotional response has been changed in these individuals even after abstinence. In a research done by Kalechstein et al. ([@B9]), apathy was a significant finding in cocaine abusers, even after 5 days abstinence. In another study, conducted on individuals with methamphetamine use disorder using a facial emotion recognition task, decreased ability of emotion identification was observed in the patient group ([@B9]).

However, in one study, no difference was found in recognizing emotional faces between cocaine abusers and normal people ([@B20]). As there are some degrees of weakness in emotion recognition in substance abusers, there may be impairment in their attention to emotion. It is hypothesized that first this deficit will continue after abstinence and second, there may be difference between morphine and methamphetamine abusers in attention to emotional stimuli. Thus, this study was designed to evaluate the pattern of attentional bias toward emotional scenes in morphine and methamphetamine abusers while they are in abstinence phase in comparison to healthy individuals. To do this, we used eye-tracking system to investigate attentional bias towards different emotions, i.e. pleasant, unpleasant, and neutral scenes.

2.. Methods
===========

2.1.. Participants
------------------

A total of 72 male volunteers older than 18 years participated in the study. Twenty-five of them were former methamphetamine abusers, who were in their abstinence period. The second group consisted of 24 ex-morphine abusers who were also on abstinence. Twenty-three healthy individuals were selected from general population as the control group. All patients were diagnosed as having substance use disorder based on Diagnostic and Statistical Manual (DSM IV). Duration of abstinence was measured based on their length of staying in rehabilitation campus (Min=10 and Max=110 days). The patients had been using just morphine or methamphetamine for at least six months prior the study. There were no symptoms of withdrawal or intoxication at the time of experiment.

All participants were interviewed using the Schedule for Affective Disorders and Schizophrenia (SADS) to rule out any major psychiatric disorders such as schizophrenia or mood disorder. They should not have had any major neurological or medical problems interfering with the task based on interview. A urine toxicology screening test was also done for all patients to rule out any use of substance during the abstinence period.

All participants gave written informed consent to participate in the study. The study was approved by the Research and Ethics Committee of Neuroscience Department at Iran University of Medical Sciences (IUMS).

2.2.. Measures and instruments
------------------------------

Hamilton Rating Scales for anxiety and depression: Since anxiety and depressive symptoms can affect attentional bias ([@B11]), Hamilton Rating Scales for Anxiety and Depression were used to evaluate these symptoms in the participants ([@B7]). Hamilton Rating Scale for Depression contains 17 items and Hamilton Rating Scale for Anxiety consists of 14 items. These two rating scales have been validated for Iranian population with good results ([@B10]).

Conners Continuous Performance Test (CPT): Since patients with substance use disorder may have some problems with response inhibition and vigilance ([@B8]), we performed CPT to evaluate these problems. Based on CPT performance, participants who were unable to complete the task or those with significant impairment in response inhibition and attentional control were excluded from the study.

2.3.. Stimuli
-------------

A total of 118 images representing emotional and neutral situations were taken from the International Affective Picture Battery (IAPS; Center for Research on Emotion and Attention) (Lang, Bradley, & Cuthbert, 1997). They were paired to a left--right arrangement according to four conditions: 1) neutral--neutral, 7 pairs, 2) pleasant--neutral, 16 pairs, 3) neutral-unpleasant, 18 pairs, and 4) pleasant--unpleasant, 17 pairs. The pictures were categorized in terms of valence and arousal based on the standard scores provided by the IAPS. The pictures with valence scores below 4.5 were considered as unpleasant, between 4.5 and 6 as neutral, and above 6 as pleasant. The pictures consisted of 48 neutral, 34 pleasant, and 36 unpleasant themes. There were no cues of substance use in selected pictures to avoid any attentional bias due to craving. Selection of images and designing the task was under permission of the first task designer ([@B16]). In order to present the trials, a 19-inch monitor (AOC931) with a screen refresh rate of 75 Hz, color quality of 32 bit, and a resolution of 1400×900 pixels was used. The pictures were presented by the eye-tracking device at the positions of 745.383 and 273.383, respectively. Moreover, during the study, the distance of pictures from the cross fixation point remained fixed. The size of the pictures was 425×397 mm. The background was dark.

2.4.. Eye tracking system
-------------------------

The Eye Link II video base tracker (SR research Ltd, Mississauga, Ontario, Canada) was used in this study. The system has a head mounted tracking device, which uses infrared. The distance between the participants' eyes and the center of the monitor was 55 cm.

Before presenting the pictures, the participant was asked to fixate on a black spot at the center of the screen for 3s. Then he was instructed to follow the spot through nine random places twice to bring more attention. This procedure was done for drift correction, calibration, and validation. The participants were instructed just to look at the images without any response. In our study, the sampling rate of the eye tracker was 250 Hz. The right eye was used to follow the participant's gaze. Trials were presented in a pseudorandom order and were initiated after participant fixated to a central cross for 5 s. Then, the paired pictures were presented for 3 s while the participant's visual directions were recorded. Each trial was followed by a black spot for drift correction. The two blocks of 116 trials (232 trials in total) were used. The second block contained counterbalance pictures and randomized presentation unlike the first block, to avoid space-orientation bias. Between the two parts of the trials, the participants had a 10--15 min break during which they were nourished with caffeine-free drinks and cupcake.

An eye-position remaining within a 50 pixel area for more than 100 ms was considered as fixation in this study.

2.5.. Statistical analysis
--------------------------

The variables of the analysis were as follow: Number of first fixation: this is the average number of all first fixations on all images.Duration of first fixation: this is the average time spent for the first fixation. Fixation typically lasts between 200--300 ms and ranges between 100 and over 500 ms ([@B6]). Fixations lasting at least 100 ms are considered as fixation in this study.Duration of the first gaze; this is the average time of all fixations that are made on a picture before changing the direction of gaze to other paired picture in a single trial.

All fixations taken less than 100 ms or more than 3000 ms, and all blinks were eliminated. Data sets with more than 20% missed data during the eye tracking procedure, were excluded from the study. Eye Link Data viewer was used to export the data to Microsoft excel format. Statistical analyses were carried out with the Statistical Package for the Social Sciences (SPSS), version 20 for Windows. To compare the three groups in terms of demographic and neuropsychological variables, one-way ANOVA was used. We used repeated measures ANOVA to compare the three groups in terms of eye-tracking variables.

3.. Results
===========

[Table 1](#T1){ref-type="table"} shows the comparison among the three groups in terms of demographics variables, Hamilton depression and anxiety scores, and substance related data. There were no significant differences between the groups with regard to ages of onset of substance disorder (F=1.13, P=0.29) and abstinence period (F=0.04, P=0.82). Scores of depression (F=2.24, P value=0.11) and anxiety were not significantly different among the groups (F=0.63, P=0.53). Duration of substance use was different between the groups (F=7.28, P=0.01). Significant differences between the groups were seen in terms of age and education level. Post Hoc evaluation (Bonferroni) revealed a higher mean age in the morphine group (F=5.56, P =0.006) and higher education years in healthy individuals (F=16.1, P=0.0001).

###### 

Demographics and clinical characteristics of three groups.

  Group                                    Morphine (n=20)   Methamphetamine (n=20)   Healthy control (n=20)          
  ---------------------------------------- ----------------- ------------------------ ------------------------ ------ --------
                                           Mean±SD           Mean±SD                  Mean±SD                  F      P
  Age (year)                               34.75±9.99        32.20±7.09               27.10±3.64               5.56   0.006
  Education (year)                         10.25±2.98        11.20±3.31               15±1.89                  16.1   0.0001
  Age of onset (year)                      21.85±7.37        24.55±8.63               \-                       1.13   0.29
  Duration of consumption (month)          100.75±75.22      49.95±37.73              \-                       7.28   0.01
  Abstinence (day)                         26.20±19.48       27.70±23.35              \-                       0.04   0.82
  HAM-D^[1](#TFN1){ref-type="table-fn"}^   4.7±6.44          5.65±6.08                2.1±3.46                 2.24   0.11
  HAM-A^[2](#TFN2){ref-type="table-fn"}^   2.8±4.47          1.85±2.7                 1.7±2.51                 0.63   0.53

1=Hamilton Rating Scale for Depression.

2= Hamilton Rating Scale for Anxiety

To assess the effect of group on attentional bias towards emotional scenes, repeated measures ANOVA was conducted. Different groups were entered as the between subject factor and its effect on eye-tracking variables in each emotions was evaluated. The eye-tracking variables consisted of number and duration of first fixation, duration of first gaze. Also sustained attention were considered as the within subject variables. The interaction for each emotion with each group (group X emotion) was also evaluated.

The results of the comparisons among the three groups in terms of number and duration of first fixation and duration of first gaze are presented in [Tables 2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}, and [4](#T4){ref-type="table"}.

###### 

Comparison between the three groups in terms of duration of first fixation variable using the repeated measure analysis.

  **Variable**                 **Effect**                                        **F (df)**         **P-value**                                                             
  ---------------------------- ----------------------- ------------------------- ------------------ -------------------- ---------------- ---------------- ---------------- ----------------
  Duration of first fixation   Emotion (main factor)   Neutral Mean±SD           Pleasant Mean±SD   Unpleasant Mean±SD   7.58 (2)         0.001                             
  789.30±349.65                846.88±359.60           837.03±443.24                                                                                                        
  Group                        Morphine Mean±SD        Methamphetamine Mean±SD   Normal Mean±SD     1.39 (2)             0.25                                               
  756.07±426.97                778.31±426.97           938.83±426.97                                                                                                        
  Emotion × Group              Morphine                Methamphetamine           Normal             1.84 (4)             0.94                                               
  Neutral                      Pleasant                Unpleasant                Neutral            Pleasant             Unpleasant       Neutral          Pleasant         Unpleasant
  Mean ±SD                     Mean ±SD                Mean ±SD                  Mean ±SD           Mean ±SD             Mean ±SD         Mean ±SD         Mean ±SD         Mean ±SD
  725.34± 132.66               774.61± 129.80          768.25± 145.33            743.32± 136.74     808.82± 156.90       782.80± 163.96   899.23± 569.29   957.22± 583.30   960.04± 733.53

###### 

Comparison between the three groups in terms of number of first fixation variable using the repeated measure analysis.

  **Variable**               **Effect**                                        **F (df)**         **P-value**                                                    
  -------------------------- ----------------------- ------------------------- ------------------ -------------------- ------------- ------------- ------------- --------------
  Number of first fixation   Emotion (main factor)   Neutral Mean±SD           Pleasant Mean±SD   Unpleasant Mean±SD   8.36 (2)      0.0001                      
  47.42±6.49                 54.03±7.64              51.65±8.60                                                                                                  
  Group                      Morphine Mean±SD        Methamphetamine Mean±SD   Normal Mean±SD     3.37 (2)             0.04                                      
  50.78±0.6                  51.20±0.6               51.11±0.6                                                                                                   
  Emotion × Group            Morphine                Methamphetamine           Normal             3.29 (4)             0.01                                      
  Neutral                    Pleasant                Unpleasant                Neutral            Pleasant             Unpleasant    Neutral       Pleasant      Unpleasant
  Mean ±SD                   Mean ±SD                Mean ±SD                  Mean ±SD           Mean ±SD             Mean ±SD      Mean ±SD      Mean ±SD      Mean ±SD
  48.4± 6.57                 51.1± 5.88              52.85± 7.28               44.75± 6.52        54.30± 6.44          54.55± 6.41   49.10± 5.81   56.70± 9.42   47.55± 10.36

###### 

Comparison between the three groups in terms of duration of first gaze variable using the repeated measure analysis.

  **Variable**          **Effect**                                        **F (df)**         **P-value**                                                                
  --------------------- ----------------------- ------------------------- ------------------ -------------------- ----------------- ----------------- ----------------- -----------------
  First gaze duration   Emotion (main factor)   Neutral Mean±SD           Pleasant Mean±SD   Unpleasant Mean±SD   5.42 (1.52)       0.01                                
  2219.73±744.43        2513.45±1060.17         2358.76±734.35                                                                                                          
  Group                 Morphine Mean±SD        Methamphetamine Mean±SD   Normal Mean±SD     4.77 (2)             0.12                                                  
  2051.89±771.5         2324.78±771.5           2715.23±771.5                                                                                                           
  Emotion × Group       Morphine                Methamphetamine           Normal             11.10 (3.05)         0.0001                                                
  Neutral               Pleasant                Unpleasant                Neutral            Pleasant             Unpleasant        Neutral           Pleasant          Unpleasant
  Mean ±SD              Mean ±SD                Mean ±SD                  Mean ±SD           Mean ±SD             Mean ±SD          Mean ±SD          Mean ±SD          Mean ±SD
  2152.34 ±567.07       1726.83 ±615.81         2276.51 ±629.86           2085.31 ±873.63    2624.90 ±1042.18     2264.14 ±651.86   2421.53 ±754.59   3188.63 ±938.38   2535.64 ±896.35

There was a significant main effect of emotion on duration of first fixation (F=7.58, P=0.001). Pairwise comparison showed that the time spent to fixate on unpleasant images was more than that of neutral ones (P=0.0001). Moreover, duration of the first fixation on pleasant images was more than that of the neutral scenes (P=0.01). The repeated measures analysis showed no significant effect of group and group x emotion interaction with regard to duration of first fixation ([Table 2](#T2){ref-type="table"}).

The main effect of group × emotion interaction was significant in terms of number of first fixation (F=3.29, P=0.01). Normal group made more fixations on pleasant and fewer fixations on unpleasant images compared to the other two groups. The morphine group had the lowest number of first fixation to pleasant images (F=8.36, P=0.0001) while this number was higher in unpleasant images in the former methamphetamine abusers ([Table 3](#T3){ref-type="table"}).

The main effect of emotion on the number of first fixation was significant (F=8.36, P=0001) ([Table 3](#T3){ref-type="table"}). The pairwise comparison showed that fixations on pleasant images were more than the neutral ones (P=0.0001). This analysis showed the higher number of first fixation on unpleasant scenes compared to the neutral images (P=0.03).

The analysis showed the significant main effect of group x emotion interaction in terms of first gaze duration (F=11.10, P=0.0001) ([Table 4](#T4){ref-type="table"}). The pairwise comparison revealed the significant difference just between the morphine and healthy groups (P=0.01). Individuals with a history of morphine use spent less time on their first gaze on pleasant scenes, while healthy people's first gaze duration was longer on pleasant images ([Table 4](#T4){ref-type="table"}).

4.. Discussion
==============

In this study, we investigated the effect of substance use (morphine and methamphetamine) on attentional bias towards pleasant, unpleasant, and neutral images during abstinence period compared to healthy individuals. Attention to emotion is a basic component of emotion perception ([@B18]) and its variation is based on individual and emotional situations and differences ([@B3]; [@B17]).

Several studies have emphasized the differences of emotional experiences in individuals with substance use disorder ([@B2]; [@B5]). The study aimed to evaluate visual attentional bias towards emotional scenes in these patients during their abstinence phase. The findings of this study revealed that the number and duration of first fixations and also duration of first gazes towards emotional scenes were different between the groups. In both patient groups, the average number of first fixations to unpleasant images was more compared to pleasant and neutral images. It means that individuals with substance use disorder tend towards unpleasant pictures. However, the time spent on fixation was longer in pleasant images.

In morphine group, duration of the first gaze to pleasant images was shorter compared to neutral and unpleasant scenes. This pattern is in contrast to what was found in normal group whose first gaze duration to pleasant pictures was longer compared to neutral and unpleasant ones. This finding is in line with a study performed on patients with heroin use disorder using event related potential (ERP) technology ([@B13]). Pleasant, unpleasant, and neutral images were shown to the patients and during that time, an auditory oddball task was conducted to assess the effect of an interfering variable on the attention to emotional scenes. The results showed that the healthy group had more attention to pleasant images. However, the patient group had more attentional bias towards unpleasant and neutral pictures.

In our study, in methamphetamine group, duration of first gazes to pleasant images was longer compared to neutral and unpleasant scenes. This pattern is similar to what was found in healthy people and different from morphine group. A lower capacity of face emotion recognition has been shown in a research conducted on methamphetamine abusers ([@B21]). One explanation for this difference is that our participants were in abstinence period while the mentioned study's subjects were in active phase.

There are studies whose findings are in line with ours. For instance, difference in emotional perception in abstinence phase was evaluated in a study showing emotional images to the patients while they were scoring their arousal and valence related to these pictures ([@B1]). Their results showed that individuals with substance use disorder had rated pleasant images with lower arousal scores compared to healthy group. Clinical feedbacks of the patients after a long period of abstinence also showed that they had lower response to emotional and affective stimuli. They mentioned that their emotional life (such as family, sex partner, etc.) had not been an emotionally stimulating factor.

There is a research that compared patients in active and abstinence phases while evaluating apathy, executive functions, and disinhibition ([@B19]). The results showed lower valence rating of pleasant images and higher arousal rating of unpleasant pictures in patients during the active phase compared to the patients in abstinent phase and healthy individuals.

Our results showed that individuals with a history of methamphetamine use disorder gazed longer on pleasant pictures while patients with morphine use disorder attended more on unpleasant images. This difference can lead to the conclusion that morphine can influence more on emotion perception and emotion regulation compared to methamphetamine. One strong point of our study was selecting patients who had been using pure morphine and methamphetamine. This selection made the comparison more precisely.

Our findings also indicate that emotion perception deficits found in patient groups are not due to active phase of substance use. However, we do not know whether these impairments are caused by long period of substance use or a primary deficit. To know that, we need to evaluate individuals at high risk of substance use disorder and compare them with patients in active and abstinence phases.

In summary our findings showed that patients with morphine use disorder have less attention towards pleasant images compared to methamphetamine and normal groups. Healthy individuals have higher tendency to look at pleasant pictures compared to other two groups. Based on our findings, it seems that patients with a history of morphine use disorder have more problems with emotion perception and regulation and they need to be engaged more in treatments focusing on these components.
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